| Autor: |
M. Sahan, M. Yılmaz, Y. Gokel, E.S. Erden, A. Karakus |
| Jazyk: |
English<br />Portuguese |
| Rok vydání: |
2013 |
| Předmět: |
|
| Zdroj: |
Revista Portuguesa de Pneumologia, Vol 19, Iss 5, Pp 200-203 (2013) |
| Druh dokumentu: |
article |
| ISSN: |
0873-2159 |
| DOI: |
10.1016/j.rppneu.2012.12.003 |
| Popis: |
Objective: We conducted this prospective study to expand available information in relation to serum phosphate levels in treatment of acute asthma. A β-adrenergic agonist, salbutamol, was used for this purpose. Material and methods: Twenty-six patients who met the inclusion criteria as; age over 16 years, asthma history, and an acute exacerbation were included. Serum blood urea nitrogen, creatinine, glucose were within normal limits in all the patients. None of the patients were on chronic theophylline therapy. Baseline serum phosphate and potassium levels were measured. Nebulized salbutamol (2.5 mg) was used three times at every hour. After 60 min, serum phosphate and potassium levels were measured. Results: Serum phosphate levels decreased from 3.7 ± 0.9 mg/dL (baseline) to 3.6±0.9 mg/dL at 60 min. This decrease was not statistically significant (p = 0.373). Serum potassium levels decreased significantly (p |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
